WeVote
Log In

Bill

Bill

HF 3273

Maternal death studies conducted by the commissioner of health expanded to include maternal morbidity.

2025-2026 Regular Session Introduced by Esther Agbaje and 3 co-sponsors

Expands Minnesota maternal health studies to include maternal morbidity, linking deaths and serious nonfatal pregnancy complications to improve policy and care.

Author added Virnig
#death #healthandhealthdepartment #women
0
WeVote Research Nonpartisan
Bill Summary · HF 3273

Summary of HF 3273 (Minnesota, 2025-2026)

Purpose

HF 3273 expands the scope of maternal death studies conducted by the Minnesota Commissioner of Health to also include maternal morbidity. The bill aims to enhance understanding of both deaths and non-fatal health complications related to pregnancy, with the goal of informing policy, improving maternal health services, and reducing preventable maternal harm.

Key Provisions and Changes

  • Expanded study scope:

    • Current framework: Maternal death reviews and studies conducted by the Commissioner of Health.
    • New provision: Include maternal morbidity in the ongoing or future maternal health studies and analyses. This broadens the public health surveillance and data collection beyond fatalities to encompass serious non-fatal complications associated with pregnancy and childbirth.

  • Authority and responsibility:

    • The Minnesota Department of Health (MDH) would be tasked with designing, conducting, and reporting on studies that cover both maternal deaths and maternal morbidity.
    • Potentially involves the creation or enhancement of data collection mechanisms, multidisciplinary review processes, and integration with existing maternal health programs.

  • Reporting and dissemination:

    • Anticipated requirements for regular reports or findings to inform policymakers, healthcare providers, and the public.
    • Emphasis on translating findings into actionable recommendations to improve maternal health outcomes.

  • Collaboration and stakeholders:

    • Possible inclusion of healthcare professionals, hospitals, public health entities, and relevant state agencies in the study design and analysis.
    • May encourage coordination with maternal health initiatives, perinatal quality collaboratives, and other maternal health improvement efforts.

Who is Affected

  • Minnesota residents who give birth or experience pregnancy-related morbidity: The data will better reflect the experiences and outcomes of pregnant individuals, not only those who die but also those who suffer serious complications.
  • Healthcare providers and facilities: Beneficiaries of improved guidelines, surveillance data, and potential quality improvement recommendations.
  • State public health system: MDH would gain expanded mandate and resources to monitor, analyze, and report on maternal health outcomes.

Procedural and Timeline Aspects

  • Legislative action history:

    • May 1, 2025: Author added Virnig.
    • April 30, 2025: Introduction and first reading; referred to Health Finance and Policy committee.

  • Next steps (typical process):

    • Committee consideration and potential amendments in Health Finance and Policy.
    • Passage by one or both chambers of the Minnesota Legislature.
    • Approval by the Governor to become law.
    • Implementation timeline would be determined during the bill’s development and any accompanying fiscal notes (not provided in the current summary).

Fiscal and Implementation Considerations

  • The summary does not include specific appropriations or budget impacts. If the bill includes funding to support expanded surveillance, data systems, staff, or reporting efforts, those details would appear in fiscal notes or subsequent amendments.

If you’d like, I can tailor this summary to include potential fiscal implications or compare HF 3273 to existing Minnesota maternal health surveillance programs.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.